Protalix BioTherapeutics, Inc. Shareholders' Equity
Protalix BioTherapeutics, Inc. (PLX) had Shareholders' Equity of $71.40 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-12
- 2026-06-30: Stockholders' Equity Attributable to Parent $71.40M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $67.23M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $48.23M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $52.91M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $71.40M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $67.23M 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $48.23M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $52.91M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $49.90M 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $45.21M 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $43.21M 10-Q · filed 2026-08-12 | |
| 2024-09-30 | $32.44M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $28.58M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $29.79M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $33.57M 10-K · filed 2026-03-18 | |
| 2023-09-30 | $38.25M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $39.00M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $1.01M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | -$10.64M 10-K · filed 2026-03-18 | |
| 2022-09-30 | -$11.51M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | -$9.89M 10-Q · filed 2023-11-06 | |
| 2022-03-31 | -$7.49M 10-Q · filed 2023-08-07 | |
| 2021-12-31 | -$6.04M 10-K · filed 2025-03-17 | |
| 2021-09-30 | $213.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $3.84M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $14.50M 10-Q · filed 2022-08-15 | |
| 2020-12-31 | -$27.04M 10-K · filed 2024-03-14 | |
| 2020-09-30 | -$33.31M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$34.76M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | -$30.88M 10-Q · filed 2021-08-16 | |
| 2019-12-31 | -$70.32M 10-K · filed 2023-02-27 | |
| 2019-09-30 | -$70.85M 10-Q · filed 2020-10-29 | |
| 2019-06-30 | -$67.48M 10-Q · filed 2020-10-29 | |
| 2019-03-31 | -$59.85M 10-Q · filed 2020-08-10 | |
| 2018-12-31 | -$52.88M 10-K · filed 2022-03-31 | |
| 2018-09-30 | -$47.94M 10-Q · filed 2019-11-07 | -$64.99M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$42.74M 10-Q · filed 2019-11-07 | -$49.57M 10-Q · filed 2018-08-09 |
| 2018-03-31 | -$35.44M 10-Q · filed 2019-08-08 | -$39.44M 10-Q · filed 2018-05-09 |
| 2017-12-31 | -$29.46M 10-K · filed 2021-03-30 | -$31.29M 10-K · filed 2018-03-06 |
| 2017-09-30 | -$26.07M 10-Q · filed 2019-03-18 | |
| 2017-06-30 | -$20.67M 10-Q · filed 2019-03-18 | |
| 2017-03-31 | -$68.47M 10-Q · filed 2019-03-18 | |
| 2016-12-31 | -$9.96M 10-K · filed 2020-03-12 | |
| 2016-09-30 | -$15.10M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | -$7.98M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $2.65M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $10.87M 10-K · filed 2019-03-18 | |
| 2015-09-30 | -$68.51M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | -$65.14M 10-Q · filed 2016-08-08 | |
| 2015-03-31 | -$61.15M 10-Q · filed 2016-05-09 | |
| 2014-12-31 | -$55.60M 10-K · filed 2018-03-06 | |
| 2014-09-30 | -$47.69M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | -$39.79M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | -$33.58M 10-Q · filed 2015-05-07 | |
| 2013-12-31 | -$26.95M 10-K · filed 2017-03-16 | |
| 2013-09-30 | -$16.71M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | -$11.99M 10-Q · filed 2014-08-07 | |
| 2013-03-31 | -$6.28M 10-Q · filed 2014-05-08 | |
| 2012-12-31 | -$3.36M 10-K · filed 2016-03-08 | |
| 2012-09-30 | $4.77M 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $7.86M 10-Q · filed 2013-08-08 | |
| 2012-03-31 | -$6.46M 10-Q · filed 2013-05-09 | |
| 2011-12-31 | -$26.08M 10-K · filed 2015-03-12 | |
| 2011-09-30 | -$17.35M 10-Q · filed 2012-11-07 | |
| 2011-06-30 | -$8.70M 10-Q · filed 2012-08-03 | |
| 2011-03-31 | $4.71M 10-Q · filed 2012-05-09 | |
| 2010-12-31 | -$11.32M 10-K · filed 2014-03-13 | |
| 2010-09-30 | -$3.54M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | -$1.55M 10-Q · filed 2011-08-08 | |
| 2009-12-31 | $15.88M 10-K · filed 2013-02-28 | |
| 2008-12-31 | $44.35M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |